BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Diagnosis
10 results:

  • 1.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Jazbec T; Girod PP; Url C; Thomé C; Riechelmann H; Sprinzl GM; Fraedrich G; Virgolini IJ
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):94-99. PubMed ID: 30630744
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
    Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
    BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression of fhit, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential.
    Koc M; Aktimur R; Kagan Gokakin A; Atabey M; Koyuncu A; Elagoz S; Topcu O
    J BUON; 2015; 20(2):567-72. PubMed ID: 26011351
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
    Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
    Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
    Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
    Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cytologic features of granulosa cell tumors in fluids and fine needle aspiration specimens.
    Lal A; Bourtsos EP; Nayar R; DeFrias DV
    Acta Cytol; 2004; 48(3):315-20. PubMed ID: 15192945
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic abnormalities in pancreatic cancer.
    Moore PS; Beghelli S; Zamboni G; Scarpa A
    Mol Cancer; 2003 Jan; 2():7. PubMed ID: 12537585
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Alterations of the fragile histidine triad gene, fhit, and its encoded products contribute to testicular germ cell tumorigenesis.
    Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA
    Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular pathobiology of pancreatic adenocarcinoma.
    Mangray S; King TC
    Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.